Technology

Stealth BioTherapeutics

$1.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+4.07%) Today
-$0.04 (-2.23%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MITO and other stocks, options, and ETFs commission-free!

About MITO

Stealth BioTherapeutics Corp. ADS, also called Stealth BioTherapeutics, is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Newton, MA. The listed name for MITO is Stealth BioTherapeutics Corp. ADS.

CEO
Irene P. McCarthy
Employees
73
Headquarters
Newton, Massachusetts
Founded
2006
Market Cap
83.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
439.96K
High Today
$1.87
Low Today
$1.64
Open Price
$1.69
Volume
626.77K
52 Week High
$5.00
52 Week Low
$0.9002

Collections

MITO Earnings

-$0.04
-$0.02
$0.00
$0.02
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 31, Pre-Market

You May Also Like

RYE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure